Drug Delivery: Global Industry Guide - Biologics Market Research

Drug Delivery: Global Industry Guide

Published Date: December 2005
Published By: Datamonitor
Page Count: 95
Order Code: R313-12315
Price: $795.00 Online Download
$1,193.00 Regional License - US
$1,590.00 Global Site License
Note: If you don't see the format or license type you require, please contact a customer service representative for assistance.
DESCRIPTION
Datamonitor's Drug Delivery: Global Industry Guide is an essential resource for top-level data and analysis covering the drug delivery industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report
* Contains an executive summary and data on value and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
* Covers Global, European, Asia-Pacific & 5 individual country markets
* Includes a five-year forecast of the industry
Highlights
Drug delivery has become an influential part of the pharmaceuticals industry in recent years and is now an important source of revenue and innovation.
By optimizing therapeutic performance, new drug delivery technologies have the potential to increase the life cycle of drugs.
The injectable drugs market is likely to prove a lucrative growth area for the leading players moving into the forecast period.
Why you should buy this report:
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Definition
Drug delivery systems are mechanisms by which therapeutic agents are introduced into the body, and directed in a controlled way towards a target organ or site of action. Conventional drug delivery forms are simple oral, topical, inhaled or injection formulations. More sophisticated delivery systems take into account pharmacokinetic principles, specific drug characteristics and variability of response between one individual and another and within the same individual under different conditions. The market value in this report reflects revenues generated through the sale or licensing of drug delivery systems. Any currency conversions used in the creation of this report have been calculated using constant 2004 annual average exchange rates.
For the purposes of this report, Asia-Pacific consists of Japan, China, New Zealand, Australia, India, Taiwan, Indonesia, Philippines, Thailand, Hong Kong, Malaysia and Singapore.
Europe consists of France, Germany, the UK, Belgium, Italy, the Netherlands, Spain, Austria, the Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Norway, Poland, Portugal,
Russia, Sweden, Switzerland and Turkey.
The global market consists of Europe, Asia-Pacific, the US, Canada, Mexico, Brazil, Argentina and South Africa.